Embryonic histological changes in rats exposed to different doses of cyclophosphoamide
DOI:
https://doi.org/10.36320/ajb/v16.i2.17565Keywords:
cyclophosphoamide, epidermis , embryonic, histology.Abstract
Cyclophosphamide is a common anticancer drug that belongs to the nitrogen mustard group of alkylating agents, their acts by adding an alkyl group to DNA. Due to this cytotoxic property it is used extensively in a variety of carcinomas singly or in combination with other drugs to treat a variety of cancers. Therefore, the present study was conducted to compare and correlate histomorphological alterations in different anatomical sites of embryonic wistar albino rats induced by a gradual increase in cyclophosphoamide dose administered intraperitoneally through maternal delivery. Laboratory wistar albino rats were injected with different bolus doses of cyclophosphoamide intraperitoneally and rat pups were dissected after delivery . Liver and skin tissues were examined histologically and compared to control animals. Results: histological examination of all tissues in both groups shows gradual cytotoxic effect of cyclophosphoamide reaching extreme histological damage with increased bolus dose. Tissue damage included hemorrhaging and lymphocytic collection. There is a significant epidermal thickness between the control group and the groups treated with different cyclophosphoamide concentrations
Downloads
References
Alhowail, A., et al. (2019). Effect of Cyclophosphamide and Its Combination with Metformin on the Survival Rate in Mice. Journal of Pharmaceutical Research International, 1-6.
Ataya, K. M., Pydyn, E. F., & Ramahi-Ataya, A. J. (1990). The effect of “activated” cyclophosphamide on human and rat ovarian granulosa cells in vitro. Reproductive Toxicology, 4(2), 121-125.
Sharbaugh, R. J., & Grogan, J. B. (1969). Suppression of Reticuloendothelial Function in the Rat with Cyclophosphamide. Journal of Bacteriology, 100(1), 117-122.
Saoji, V. (2008). Premature ovarian failure due to cyclophosphamide: A report of four cases in dermatology practice. Indian Journal of Dermatology, Venereology and Leprology, 74(2), 128.
Qiu, J., Hales, B. F., & Robaire, B. (1995). Effects of Chronic Low-Dose Cyclophosphamide Exposure on the Nuclei of Rat Spermatozoa1. Biology of Reproduction, 52(1), 33-40.
Burnstock, G., Vaughn, B., & Robson, S. C. (2013). Purinergic signalling in the liver in health and disease. Purinergic Signalling, 10(1), 51-70.
Trasler, J. M., Hales, B. F., & Robaire, B. (1986). Chronic Low Dose Cyclophosphamide Treatment of Adult Male Rats: Effect on Fertility, Pregnancy Outcome and Progeny1. Biology of Reproduction, 34(2), 275-283.
Sulkowska, M., et al. (1998). Cyclophosphamide-induced generation of reactive oxygen species. Comparison with morphological changes in type II alveolar epithelial cells and lung capillaries. Experimental and Toxicologic Pathology, 50(3), 209-220.
Corsi, A., Calabresi, F., & Greco, C. (1978). Comparative effects of cyclophosphamide and isophosphamide on Lewis lung carcinoma. British Journal of Cancer, 38(5), 631-633.
Emmenegger, U., et al. (2007). Pharmacodynamic and pharmacokinetic study of chronic low-dose metronomic cyclophosphamide therapy in mice. Molecular Cancer Therapeutics, 6(8), 2280-2289.
Pearson, R., et al. (2002). Purinergic and Muscarinic Modulation of the Cell Cycle and Calcium Signaling in the Chick Retinal Ventricular Zone. The Journal of Neuroscience, 22(17), 7569-7579.
Allcorn, S., Catsicas, M., & Mobbs, P. (1996). Developmental Expression and Self-regulation of Ca2+Entry via AMPA/KA Receptors in the Embryonic Chick Retina. European Journal of Neuroscience, 8(12), 2499-2510.
Mishra, S. K. (2006). Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation. Development, 133(4), 675-684.
Peng, H., et al. (2016). Purinergic and Store-Operated Ca2+ Signaling Mechanisms in Mesenchymal Stem Cells and Their Roles in ATP-Induced Stimulation of Cell Migration. STEM CELLS, 34(8), 2102-2114.
Greig, A. V. H., Linge, C., & Burnstock, G. (2008). Purinergic receptors are part of a signalling system for proliferation and differentiation in distinct cell lineages in human anagen hair follicles. Purinergic Signalling, 4(4), 331-338.
Liu, S., Zhang, H., & Duan, E. (2013). Epidermal Development in Mammals: Key Regulators, Signals from Beneath, and Stem Cells. International Journal of Molecular Sciences, 14(6), 10869-10895.
Burnstock, G. (2006). Historical review: ATP as a neurotransmitter. Trends in Pharmacological Sciences, 27(3), 166-176.
Langer, D., et al. (2007). The ectonucleotidases alkal ine phosphatase and nucleoside triphosphate diphosphohydrolase 2 are associated with subsets of progenitor cell populations in the mouse embryonic, postnatal and adult neurogenic zones. Neuroscience, 150(4), 863-879.
Neary, J. T., et al. (1999). Mitogenic Signaling by ATP/P2Y Purinergic Receptors in Astrocytes: Involvement of a Calcium-Independent Protein Kinase C, Extracellular Signal-Regulated Protein Kinase Pathway Distinct from the Phosphatidylinositol-Specific Phospholipase C/Calcium Pathway. The Journal of Neuroscience, 19(11), 4211-4220.
Khalfa, H. M., Albideri, A., & Jaffat, H. S. (2018). Cytological and Histological Study of Adult and Neonate Epidermis in Thick and Thin Skin of Various Anatomical Sites. International Journal of Pharmaceutical Quality Assurance, 9(2).
Khalfa, H. M., Albideri, A., & Jaffat, H. S. (2018). Histological and cytoarchitectural measurements of human epidermis in different anatomical sites of embryonic, fetal and neonatal Iraqi subjects in Al‐Hilla/Iraq Maternity Hospital. Journal of pharmaceutical science & research, 10(4), 812-818.
Li, D., et al. (2012). Roles of Purinergic Receptor P2Y, G Protein–Coupled 12 in the Development of Atherosclerosis in Apolipoprotein E–Deficient Mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 32(8).
Alarcón-Vila, C., Pizzuto, M., & Pelegrín, P. (2019). Purinergic receptors and the inflammatory response mediated by lipids. Current Opinion in
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Hydar M Khalfa, haider L Al-msaid, hawara muhsin
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
